ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer

Summary

This phase II trial is studying how well ABI-007 works in treating patients with persistent or recurrent cervical cancer. Drugs used in chemotherapy, such as ABI-007, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Timeline

Start

2006-11

Primary completion

2011-02

Completion

—

Drugs

Indications